Agilent 100 Automated Disintegration Tester

Overview

The Agilent 100 Automated Disintegration Tester is a precision-engineered, offline pharmaceutical testing instrument designed to perform standardized disintegration testing of solid oral dosage forms—including tablets, capsules, and suppositories—in strict compliance with United States Pharmacopeia (USP) and other internationally recognized pharmacopoeial requirements. Based on the principle of mechanical immersion and cyclic vertical movement of dosage units in a controlled-temperature aqueous medium, the system quantifies the time required for complete disintegration into particles or soft masses that pass through a specified mesh screen. This measurement serves as a critical quality attribute correlating directly with dissolution behavior and, ultimately, bioavailability of the active pharmaceutical ingredient (API). The Agilent 100 integrates a reciprocating drive mechanism, thermostatically regulated water bath, integrated heater/circulator, and three independently operable baskets into a single compact unit—eliminating external controllers, auxiliary baths, or third-party accessories. Its architecture supports robust, repeatable operation under routine QC laboratory conditions while maintaining full traceability and operational consistency across shifts and users.

Key Features

• Triple-basket configuration enables concurrent testing of up to three samples under identical or individually programmed conditions
• Independent basket programming via intuitive front-panel keypad—each basket can be assigned unique test duration, lift frequency, and post-test basket lift sequence
• Precise temperature control with ±0.1 °C accuracy over a range of ambient +5 °C to 55 °C; rapid thermal equilibration (<5 min to setpoint) ensured by high-efficiency heater/circulator subsystem
• Stable 30 ±1 RPM vertical reciprocation rate, mechanically synchronized across all baskets to meet USP specification for motion profile fidelity
• Compact footprint (≤0.4 m²) optimizes benchtop utilization in space-constrained QC labs without compromising accessibility or serviceability
• Quick-disconnect fluid couplings allow full drainage and cleaning of the 8-L water bath within minutes—supporting GLP-aligned hygiene protocols and cross-product changeover efficiency
• Front-panel LED display provides real-time feedback of bath temperature, elapsed time, basket position status, and system fault codes

Sample Compatibility & Compliance

The Agilent 100 accommodates standard USP-compliant disintegration baskets (Type I and Type II), tablet holders, and capsule holders. It supports testing of immediate-release and modified-release formulations per USP , European Pharmacopoeia (Ph. Eur.) 2.9.1, and Japanese Pharmacopoeia (JP) 6.05 specifications. All hardware components—including basket frames, shafts, and water bath liner—are constructed from corrosion-resistant, non-reactive materials (e.g., stainless steel 316L and borosilicate glass) suitable for repeated exposure to acidic, alkaline, or surfactant-containing media. The system design inherently satisfies core elements of FDA 21 CFR Part 11 readiness when paired with optional audit-trail-enabled software (e.g., Agilent PharmaSuite), including electronic signatures, user access controls, and immutable event logging for regulatory inspections.

Software & Data Management

While the Agilent 100 operates as a stand-alone instrument with local keypad control, it is fully compatible with Agilent’s validated pharmaceutical data management ecosystem. When connected to Agilent PharmaSuite or third-party LIMS via RS-232 or USB-to-serial interface, the instrument transmits timestamped parameters—including start/stop time, actual bath temperature (every 10 s), basket lift count, and end-of-test confirmation signals. Optional thermal printer integration provides hard-copy documentation of test initiation, parameter verification, and completion status—supporting paper-based SOP adherence where required. All data outputs are structured in CSV format for direct import into statistical process control (SPC) platforms or electronic batch record (EBR) systems.

Applications

• QC release testing of commercial tablet and capsule batches against compendial disintegration limits
• Stability-indicating method development for formulation optimization (e.g., binder selection, lubricant impact assessment)
• Comparative evaluation of generic vs. reference listed drug (RLD) disintegration profiles
• Process validation support—monitoring disintegration consistency across multiple manufacturing runs
• Investigations of excipient–API interactions affecting wetting and erosion kinetics
• Pre-formulation screening of novel delivery systems (e.g., orally disintegrating tablets, buccal films)

FAQ

Does the Agilent 100 comply with USP mechanical specifications for basket motion and temperature stability?
Yes—the instrument meets all dimensional, stroke length (55 ±1 mm), cycle rate (29–32 cycles/min), and thermal uniformity requirements defined in USP . Calibration certificates are provided with each unit.
Can the three baskets operate at different temperatures simultaneously?
No—temperature is controlled at the bath level; all baskets share the same thermal environment. Independent temperature control per basket is not supported.
Is the water bath volume sufficient for extended testing at elevated temperatures?
Yes—the 8-L capacity ensures stable thermal mass and minimizes evaporation-induced drift during multi-hour tests at 37 °C or 45 °C.
What maintenance intervals are recommended for routine operation?
Daily visual inspection of basket integrity and seal integrity; weekly cleaning of bath interior and drain lines; annual calibration verification of temperature sensor and timing circuitry per internal SOP or ISO/IEC 17025 guidelines.
Is IQ/OQ documentation available for this instrument?
Yes—Agilent provides factory-validated Installation Qualification (IQ) and Operational Qualification (OQ) protocols, including pre-executed test scripts and acceptance criteria aligned with ASTM E2500 and EU Annex 15.